Clinical Trials · NCT02375464

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

No Longer AvailableN/AOctreotide (Unclear)
Phase
N/A
Recruitment status
No Longer Available
Sponsor
Northwell Health
Enrollment
0
Start date
Apr 2015
Locations
See registry
Primary endpoint
Study in Neuroendocrine Tumors
View Octreotide compound reference